Hemostasis Learning Essentials - Series 2 Assessment

Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Continue Untitled Scene Master Template HOOD05162003052540 | Effective Date: 26-Nov-2019 Hemostasis Learning Essentials Series 2 – Bleeding Disorders Assessment This assessment covers the content in the Series 2 topic. Welcome ? Objectives-Series 2 Webinars It is recommended that the webinars in the Hemostasis Learning Essentials Series 2- Bleeding Disorders are completed prior to taking this assessment. Select each webinar title to review the learning objectives. Bleeding Risk Assessment-Pre-analytical Aspect Webinar Bleeding Risk Assessment-Most Common Bleeding Disorders Webinar Hemophilia and Von Willebrand Disease Webinar Objectives Hemophilia and Von Willebrand Disease Webinar At the end of this session you will be able to: Describe the types of Von Willebrand disease, diagnosis and general treatments Describe the clinical presentation and diagnosis of hemophilia in adults, newborns and older children Describe the clinical testing, interpretation and treatment of hemophilia Bleeding Risk Assessment-Most Common Bleeding Disorders Webinar At the end of this session you will be able to: Identify the most common bleeding disorders Describe the methodologies and assays used to diagnose and measure bleeding disorders Bleeding Risk Assessment-Pre-analytical Aspect Webinar At the end of this session you will be able to: Identify the most critical pre-analytic variables for bleeding risk assessment Describe how patient variables and sample preparation impact pre-analytic variables Disclaimer ? Disclaimer Assessment Start ? This assessment will test your retention of the presented content. A passing score of 80% or higher is required to complete the course and earn your certificate . Assessment questions must be answered completely to receive full credit. Partial credit will not be given for assessment questions that require multiple answers. You may repeat the assessment as many times as needed. Assessment Select the best answer. ? 150,000 and 480,000 /µL 50,000 and 380,000 /µL Question 1 of 12 When preparing PRP (plasma rich protein) for Platelet Aggregation Testing, the recommended platelet count should be between________ . 100,000 and 430,000 /µL 200,000 and 530,000 /µL Multiple Choice Select the best answer. ? Von Willebrand disease Hemophilia B Question 2 of 12 Which of the following is the most common bleeding disorder? Hemophilia A DIC (Disseminated Intravascular Coaguloathy) Multiple Choice Which of the following is the most common bleeding disorder? ? Select three (3) answers. Question 3 of 12 History of liver disorders History of liver disorders History of liver disorders Which of the following can help to diagnose Von Willebrand disease? Bleeding questionnaire, anamnesis Family history of bleeding Laboratory studies confirming a Von Willebrand defect Multiple Answer One or more answers are incorrect. Select the best answer. ? Reduces platelet aggregation Increased FVIII and vWF Question 4 of 12 How does consuming caffeine affect coagulation testing? Increases CVD Increases Pro-coagulants Multiple Choice How does consuming caffeine affect coagulation testing? ? Select four (4) answers. Question 5 of 12 D-Dimer D-Dimer D-Dimer If a patient is suspected of having Von Willebrand disease (VWD), which tests support the diagnosis of VWD? PFA Screening VWF Antigen VWF Activity FVIII:C Multiple Answer One or more answers are incorrect. ? Select three (3) answers. Question 6 of 12 According to the 2021 ASH ISTH NHF WHF Guideline for Diagnosing Von Willebrand disease, which lab screenings should be performed? Factor VIII VWF:Ag Prothrombin time (PT) VWF platelet-binding activity Multiple Answer One or more answers are incorrect. ? Select three (3) answers. Question 7 of 12 Which of the following tests are used to evaluate and classify the severity of Hemophilia A? Activated partial thromboplastin time (APTT) Prothrombin time (PT) Factor X Activity Factor VIII Activity Multiple Answer One or more answers are incorrect. ? Select two (2) answers. Question 8 of 12 When assessing hemophilia factors, which methods of factor determination are used? Clot based (One-Staged Clotting assays - OSA) Chromogenic based (Chromogenic Substrate Assay - CSA) Aggregation assays Immunochemical assays Multiple Answer One or more answers are incorrect. Evaluate the Bleeding Assessment Tool (BAT) score Perform the following tests: CBC, PT/PTT, TT Perform the following tests VWF: AG, platelet-dependent VWF activity, FVIII:C 3. 2. 1. ? Drag each response to place the list in the correct order. What is the correct order of the steps in diagnosing patients suspected of having Von Willebrand disease? Question 9 of 12 Sequence One or more answers are incorrect. Severe Spontaneous bleeding into joints or muscles, predominantly in the absences of identifiable hemostatic challenge Moderate Occasional spontaneous bleeding; prolonged bleeding with minor trauma or surgery Mild Severe bleeding with major trauma or surgery, rare spontaneous bleeding Drag each response from the right column to its corresponding item in the left column. What is the classification of hemophilia severity as defined by the bleeding episodes below? ? Question 10 of 12 Matching One or more answers are incorrect. ? Select three (3) answers. Question 11 of 12 With regard to coagulation testing, which of the following is true of senior patients? Impaired Fibrinolysis Platelets are more responsive to aggregation Higher PT and APTT’s Fbg, FV, FVIII, IX, VWF, D-Dimer increase Multiple Answer One or more answers are incorrect. Select the best answer. ? Decreases INR Increases CVD Question 12 of 12 How does consuming foods containing Vitamin K, like cabbage, affect patients receiving Warfarin therapy? Increases INR Decreases CVD Multiple Choice Assessment Results YOUR SCORE: PASSING SCORE: Review Retry Retry Continue Continue Continue %Results.ScorePercent%% %Results.PassPercent%% ? Assessment Results You did not pass the course. Take time to review the assessment then select Retry to continue. Congratulations. You passed the course.. Exit To access your Certificate of Completion, select the Certificates tab from the learning activity overview page. You can also access the certificate from your PEPconnect transcript. ? You have completed the Hemostasis Learning Essentials Series 2 – Bleeding Disorders Assessment . Completion details, certificates tab Navigation Help Select the icon above to open the table of contents. Click Next to continue. Next Welcome Slide The timeline displays the slide progression. Slide the orange bar backwards to rewind the timeline. Click Next to continue. Next Tmeline Select the CC icon to display closed captioning (subtitles). Click Next to continue. Next Caption Icon Select the buttons to learn more about a topic. Be sure to review all topics before navigating to the next slide. Click Next to continue. Next Tab Arrow Slide Select the X to close the pop-up. Click Next to continue. Next Layer Slide Some images may have a magnifier icon. Select the image to see an enlarged view. Select it again to return to the normal view. Click Next to continue. Next Zoom Slide Some images have a magnifier icon in the bottom-left corner. Select these image to see an enlarged view of the image. Select the image again to return to the normal view. Videos should default to the optimal resolution. However, to change the video resolution select the gear icon. Click Next to continue. Next Video Slide Some images have a magnifier icon in the bottom-left corner. Select these image to see an enlarged view of the image. Select the image again to return to the normal view. Select Submit to record your response. Click the X in the upper right corner to exit the navigation help. Assessment Slide Question Bank 1 QR700004895| Effective Date: 30 Jan 2024 1.1 Welcome 1.2 Objectives 1.3 Disclaimer 1.4 Assessment